Modern pediatrics. Ukraine. 2019.4(100):71-74; doi 10.15574/SP.2019.100.71

Ryznychuk M. A., Pishak V. P., Kretsu T. N., Dmitruk V. P., Kostiv M. I.
Higher State Educational Establishment of Ukraine «Bukovinian State Medical University», Chernivtsi
National Academy of Pedagogical Sciences of Ukraine, Kyiv, Ukraine,
Regional Children's Clinical Hospital, Chernivtsi, Ukraine

For citation: Ryznychuk MA, Pishak VP, Kretsu TN, Dmitruk VP et al. (2019). Clinical case of incomplete form of Wolfram Syndrome. Modern pediatrics. Ukraine. 4(100): 71-74. doi 10.15574/SP.2019.100.71
Article received: Jan 19, 2019. Accepted for publication: May 16, 2019.

Full text of article

Content

Wolfram syndrome (syn: WS, DIDMOAD syndrome) is an autosomal recessive degenerative disease with a progressive course. The complete syndrome is described, which includes four components: diabetes mellitus (DM), diabetes insipidus (DI), optic nerve atrophy and sensorineural hypocusis. The incomplete form of the syndrome is manifested by a combination of diabetes mellitus and diabetes insipidus. The case of incomplete form of Wolfram syndrome is presented. The first sign of the syndrome was the development of diabetes insipidus at one year of age, and after two years, diabetes mellitus type I developed. Optic nerve atrophy and sensorineural hypocusis during the entire period of observation were not detected. Conclusions patients with diabetes insipidus should be diagnosed with diabetes mellitus type I when they are deteriorating. When discovered, the child should be suspected of having Wolfram syndrome and have a hearing and vision test for early detection of optic nerve atrophy and hypocusis.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee (LEC) of institution. The informed consent of the patient was obtained for conducting the studies.

No conflict of interest was declared by the authors

Key words: incomplete form of Wolfram syndrome, diabetes insipidus, diabetes mellitus type I, children.

REFERENCES

1. Silkina MI, Belyakova NA, Lareva AV, Konovalova OV, Rudenko EV. (2016). DIDMOAD-syndrome (Clinical observation). Vehnevolzhsky medical journal. 3 (15): 42–3.

2. Barrett TG, Bundey SE, Macleod AF. (1995). Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. The Lancet. 346 (8988): 1458–1463. https://doi.org/10.1016/S0140-6736(95)92473-6

3. Chaussenot A, Bannwarth S, Rouzier C et al. (2011). Neurologic features and genotype-phenotype correlation in Wolfram syndrome. Annals of Neurology. 69(3): 501–508. https://doi.org/10.1002/ana.22160; PMid:21446023.

4. Galluzzi P, Filosomi G, Vallone IM, Bardelli AM, Venturi C. (1999). MRI of Wolfram syndrome (DIDMOAD). Neuroradiology. 41: 729–731. https://doi.org/10.1007/s002340050832; PMid:10552021

5. Hardy C, Khanim F, Torres R. (1999). Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet. 65: 1279–1290. https://doi.org/10.1086/302609; PMid:10521293 PMCid:PMC1288280

6. Kinsley BT, Swift M, Dumont RH, Swift RG. (1995). Morbidity and mortality in the Wolfram syndrome. Diabetes Care. 18(12): 1566–1570. https://doi.org/10.2337/diacare.18.12.1566; PMid:8722052.

7. Maleki N, Bashardoust B, Zakeri A, Salehifar A, Tavosi Z. (2015). Diabetes mellitus, diabetes insipidus, optic atrophy, and deafness: A case of Wolfram (DIDMOAD) syndrome. J Curr. Ophthalmol. 27(3–4): 132–135. https://doi.org/10.1016/j.joco.2015.11.003; PMid:27239592 PMCid:PMC4881228

8. Medlej R, Wasson J, Baz P et al. (2004). Diabetes mellitus and optic atrophy: A study of Wolfram syndrome in the Lebanese population. The Journal of Clinical Endocrinology & Metabolism. 89(4): 1656–1661. https://doi.org/10.1210/jc.2002-030015; PMid:15070927.

9. Plantinga RF, Pennings RJ, Huygen PL. (2008). Hearing impairment in genotyped Wolfram syndrome patients. Ann Otol Rhinol Laryngol. 117: 494–500. https://doi.org/10.1177/000348940811700704; PMid:18700423

10. Rando TA, Horton JC, Layzer RC. (1992). Wolfram syndrome: evidence of a diffuse neurodegenerative disease by magnetic resonance imaging. Neurology. 42: 1220–1224. https://doi.org/10.1212/WNL.42.6.1220; PMid:1603350

11. Swift RG, Sadler DB, Swift M. (1990). Psychiatric findings in Wolfram syndrome homozygotes. The Lancet. 336(8716): 667–669. https://doi.org/10.1016/0140-6736(90)92157-D

12. Urano F. (2016). Wolfram Syndrome: Diagnosis, Management, and Treatment. Current Diabetes Reports. 16(1): 1–8. https://doi.org/10.1007/s11892-015-0702-6; PMid:26742931 PMCid:PMC4705145

13. Viswanathan V, Medempudi S, Kadiri M. (2008). Wolfram syndrome. J Assoc Physicians India. 56: 197–199.

14. Zmyslowska A, Fendler W, Niwald A. (2015). Retinal thinning as a marker of disease progression in patients with Wolfram syndrome. Diabetes Care. 38: e36–e37. https://doi.org/10.2337/dc14-1898; PMid:25715420

15. Zmyslowska A, Fendler W, Szadkowska A. (2015). Glycemic variability in patients with Wolfram syndrome is lower than in type 1 diabetes. Acta Diabetol. 52: 1057–1062. https://doi.org/10.1007/s00592-015-0757-5; PMid:25916214 PMCid:PMC4628085